Anti-Epileptic Drugs for Pediatrics Market

Anti-Epileptic Drugs for Pediatrics Market, By Drug Type (First generation anti-epileptic drugs, Second generation anti-epileptic drugs, Third generation anti-epileptic drugs), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Epilepsy is a common neurological disorder that affects people of all ages globally. However, it is more prevalent in children as almost 70% of epilepsy cases are diagnosed before reaching adulthood. Anti-epileptic drugs play a crucial role in managing seizures and improving quality of life for pediatric patients suffering from epilepsy. These medications work by controlling abnormal neuronal firing and synchrony in the brain to prevent seizures. In recent years, extensive research has led to the development and approval of newer generation anti-epileptic drugs that are more effective and have less side effects than the earlier drugs for pediatric use. This has positively impacted medication adherence and treatment outcomes for children with epilepsy. Pediatric epilepsy can be caused due to a trauma injury, complications during birth, or genetic disorder. Epilepsy that occurs due to brain infections such as meningitis is known as symptomatic epilepsy, while a genetics related condition is called idiopathic epilepsy.

Market Dynamics

The global anti-epileptic drugs for pediatrics market is driven by the growing prevalence of epilepsy among children. According to the World Health Organization (WHO), epilepsy affects around 1% of children worldwide. Besides this, factors such as increasing healthcare expenditures, rising awareness about epilepsy treatment, and introduction of newer anti-epileptic drugs are fueling the market growth. However, the market faces certain restraints such as high costs associated with drug development and stringent regulations for the approval of pediatric drugs. Moreover, adverse effects of anti-epileptic drugs on developing neurological system of children poses challenges. On the positive side, ongoing research on disease modifying therapies and development of personalized anti-epileptic drug regimens present notable opportunities for market players in the future.

Key features of the study:
  • This report provides an in-depth analysis of the global anti-epileptic drugs for pediatrics market, and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti-epileptic drugs for pediatrics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as part of this study include Sanofi, Eisai Co., Ltd., Pfizer Inc., UCB S.A., Sunovion Pharmaceuticals Inc., Abbott, Jazz Pharmaceuticals plc, Ovid Therapeutics Inc., SK BIOPHARMACEUTICALS, Alexza Pharmaceuticals, Inc., Taisho Pharmaceutical Holdings Co., Ltd., Marinus Pharmaceuticals, Inc., Xenon Pharmaceuticals Inc., H. Lundbeck A/S, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
  • The global anti-epileptic drugs for pediatrics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-epileptic drugs for pediatrics market
Detailed Segmentation:
  • Global Anti-Epileptic Drugs for Pediatrics Market, Drug Type:
  • First generation anti-epileptic drugs
  • Second generation anti-epileptic drugs
  • Third generation anti-epileptic drugs
  • Global Anti-Epileptic Drugs for Pediatrics Market, Route of Administration:
  • Oral
  • Injectable
  • Others (Nasal, etc.)
  • Global Anti-Epileptic Drugs for Pediatrics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Anti-Epileptic Drugs for Pediatrics Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles
  • Sanofi
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • UCB S.A.
  • Sunovion Pharmaceuticals Inc.
  • Abbott
  • Jazz Pharmaceuticals plc
  • Ovid Therapeutics Inc.
  • SK BIOPHARMACEUTICALS
  • Alexza Pharmaceuticals, Inc.
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Xenon Pharmaceuticals Inc.
  • Lundbeck A/S
  • Teva Pharmaceutical Industries Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trend Analysis
Market Dynamics
Drivers
Increasing incidence of neurological disorders
Increasing research and development activities
Restraints
Increasing product recalls by regulatory authorities
Side effects of anti-epileptic drugs
Market Opportunities
Untapped emerging markets
The rising demand for targeted therapy
Impact Analysis
Regulatory Guidelines
Product Launches
Key Development
PEST Analysis
PORTER’s Analysis
Regulatory Scenario
Mergers and Acquisitions
Manufacturer Revenue
Healthcare Spending by Country
4. Global Anti-Epileptic Drugs for Pediatrics Market - COVID-19 Impact Analysis
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Anti-Epileptic Drugs for Pediatrics Market, By Drug Type, 2018-2030, (US$ Mn)
Overview
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
First generation anti-epileptic drugs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Second generation anti-epileptic drugs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Third generation anti-epileptic drugs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
6. Global Anti-Epileptic Drugs for Pediatrics Market, By Route of Administration, 2018-2030, (US$ Mn)
Overview
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Injectable
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Others (Nasal, etc.)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
7. Global Anti-Epileptic Drugs for Pediatrics Market, By Distribution Channel, 2018-2030, (US$ Mn)
Overview
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
8. Global Anti-Epileptic Drugs for Pediatrics Market, By Region, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2019-2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018- 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018–2030, (US$ Mn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Eisai Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlight
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
UCB S.A.
Company Highlight
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sunovion Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Abbott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Jazz Pharmaceuticals plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Ovid Therapeutics Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
SK BIOPHARMACEUTICALS
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alexza Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Taisho Pharmaceutical Holdings Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Marinus Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Xenon Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Lundbeck A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 35 market data tables and 31 figures on "Global Anti-Epileptic Drugs for Pediatrics Market” – Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings